Robert Wessman
About Robert Wessman
Company: Alvogen
Robert Wessman founded Alvogen in 2009 and serves as its Executive Chairman and CEO. Under his leadership, Alvogen transformed from a small US-based contract manufacturing business into a top 15 global generics player. The company now operates in 35 countries, a significant expansion achieved within just six years. Wessman's strategic leadership and entrepreneurial vision have been key drivers in the company's growth and success.
Title: Chairman and CEO
Robert Wessman holds the titles of Chairman and CEO. His roles encompass both executive leadership and strategic oversight, guiding the company towards achieving its business objectives and maintaining its competitive edge in the global pharmaceutical market.
Education and Expertise
Robert Wessman earned a degree in Business Studies from the University of Iceland. He also served as a lecturer at the same university, highlighting his foundational expertise in business education and commitment to sharing knowledge. His academic background has been instrumental in his approach to business strategy and corporate management.
Background: Actavis Leadership
From 1999 to 2008, Robert Wessman served as the CEO and key strategist of Actavis. During his tenure, he transformed the company from a small local entity into the 4th largest global generic pharmaceutical company. Actavis expanded its operations to 55 countries under his leadership, showcasing Wessman’s ability to drive growth and scale operations on a global level.
Château de Saint-Cernin Wine Production
Robert Wessman owns Château de Saint-Cernin in France, where he produces white and red wine, as well as Champagne, under his own label. His involvement in wine production aligns with his passion for good wine. The vineyard exemplifies his diversification into other industries beyond pharmaceuticals.
Founder of Alvotech
In 2013, Robert Wessman founded the biopharmaceutical company Alvotech. He also established a state-of-the-art biosimilar development and manufacturing facility in Reykjavik, Iceland. Alvotech focuses on developing and manufacturing biosimilars, an area where Wessman has applied his extensive experience in the pharmaceutical industry to innovate and expand.